Ligand validation:6B5G

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6B5G_NAD_A_601	88%	3%	0.095	0.97	5.33	1.35	16	4	6	0	100%	1
6B5G_NAD_C_601	84%	3%	0.101	0.963	5.29	1.31	17	4	1	0	100%	1
6B5G_NAD_D_601	81%	3%	0.106	0.96	5.3	1.42	17	8	5	0	100%	1
6B5G_NAD_B_601	81%	3%	0.11	0.961	5.3	1.27	16	2	0	0	100%	1
6ALJ_NAD_D_602	88%	3%	0.09	0.964	4.82	1.55	16	10	1	0	100%	1
6B5H_NAD_A_601	51%	2%	0.169	0.925	5.34	1.55	16	9	3	0	100%	1
4X2Q_NAD_B_601	28%	45%	0.207	0.931	0.82	1.31	-	3	0	0	61%	0.5568
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.